Latest G1 Therapeutics Inc. Stories
Robust antitumor activity of G1's novel CDK4/6 inhibitors to be highlighted in poster on April 7 CHAPEL HILL, N.C., March 27, 2014 /PRNewswire/ -- G1 Therapeutics, Inc., a privately
Corporate overview to be given January 13 at 9:15 a.m. PST CHAPEL HILL, N.C., Jan. 8, 2014 /PRNewswire/ -- G1 Therapeutics, Inc. today announced that Dr.
Industry veteran and oncologist strengthens management team as G1 advances lead product candidate toward IND status CHAPEL HILL, N.C., Jan.
- A transitional zone between two communities containing the characteristic species of each.